2018
DOI: 10.1016/j.cmrp.2018.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Methicillin-resistant Staphylococcus aureus : An update on the epidemiology, treatment options and infection control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
102
0
3

Year Published

2018
2018
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(112 citation statements)
references
References 57 publications
2
102
0
3
Order By: Relevance
“…It was noteworthy that five strains were resistant to ceftaroline. Penicillin binding protein 2a has a low affinity to beta-lactam antibiotics comprising penicillin, cephalosporin and carbapenems except the newely approved drug, ceftaroline [30]. Such drug, a fifth generation of cephalosporins, has approved by US Food and Drug Administration (FDA) in 2010 for the treatment of MRSA skin and soft tissue infections as well as it has been used to treat MRSA in refractory cases [31].…”
Section: Discussionmentioning
confidence: 99%
“…It was noteworthy that five strains were resistant to ceftaroline. Penicillin binding protein 2a has a low affinity to beta-lactam antibiotics comprising penicillin, cephalosporin and carbapenems except the newely approved drug, ceftaroline [30]. Such drug, a fifth generation of cephalosporins, has approved by US Food and Drug Administration (FDA) in 2010 for the treatment of MRSA skin and soft tissue infections as well as it has been used to treat MRSA in refractory cases [31].…”
Section: Discussionmentioning
confidence: 99%
“…Vancomycin has been the choice in the treatment of infections by this resistant pathogen [58]. However, in the late 1990s, MRSA strains with reduced susceptibility to vancomycin were isolated and, eventually, vancomycin-resistant Staphylococcus aureus (VRSA) strains were later detected [59]. Some HA-MRSA clones, usually associated with nosocomial infections, have spread to the community.…”
Section: Methicillin-resistant S Aureusmentioning
confidence: 99%
“…However, recently, other pathogens have gained importance. S. aureus has become the predominant causative organism in the world, in both hospital settings as well as the community, followed by CoNS [36, 1]. Accordingly, S. aureus was the most commonly isolated pathogen (52.6%), followed by CoNS (26.3%).…”
Section: Discussionmentioning
confidence: 99%
“…S. aureus is a dangerous and versatile human pathogen because of its ability to cause various types of infections, including skin and soft tissue sepsis, pneumonia, bloodstream infections (BSIs), osteomyelitis and infective endocarditis (IE) [1]. Higher mortality rate (15–25%) was recently reported from serious S. aureus infections, particularly bacteremia and endocarditis [2,3].…”
Section: Introductionmentioning
confidence: 99%